Phase 2 trial of liposomal doxorubicin (40 mg/m(2)) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum (Q31440187)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 trial of liposomal doxorubicin (40 mg/m(2)) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum |
scientific article |
Statements
1 reference
Phase 2 trial of liposomal doxorubicin (40 mg/m(2)) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum (English)
1 reference
Markman M
1 reference
Kennedy A
1 reference
Webster K
1 reference
Peterson G
1 reference
Kulp B
1 reference
Belinson J
1 reference
1 September 2000
1 reference
1 reference
3 Pt 1
1 reference
369-372
1 reference
Identifiers
1 reference
1 reference